December 11, 2007 - The FDA issued its final assessment of two long-term studies in patients with severe gastroesophageal reflux disease (GERD) who were being treated with either Prilosec or Nexium, and finds that “long-term use of these drugs is not likely to be associated with increased risk of heart problems.”
December 11, 2007 ― GE partnered with anesthesiologists, emergency medicine physicians and other fields of medicine to ...
December 11, 2007 – Due to the loss of more than 50 percent of the North American Mo-99 supply and its impact on the ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 11, 2007 - GE’s SnapShot Pulse technology for prospectively gated diagnostic cardiac CT exams has been proven ...
December 10, 2007 - Cardica Inc. announced that leading cardiac surgeons from The Heart Hospital Baylor Plano and ...
December, 10, 2007 - Cardica Inc. today announced that leading cardiac surgeons from The Heart Hospital Baylor Plano and Centennial Medical Center in Nashville will webcast a live off-pump coronary artery bypass graft (CABG) procedure as well as a port-access robotic CABG procedure using innovative anastomotic devices from Cardica Inc. on Jan. 17, 2008.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 10, 2007 – Ymed Inc. announced that it has successfully completed its first U.S. cases with its proprietary ...
December 10, 2007 - U.S. Secretary of Health and Human Services Michael Leavitt urged Congress Dec. 4 to include a ...
December 7, 2007 — GE Healthcare has licensed a technique patented by an Eastern Virginia Medical School (EVMS) ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 7, 2007 – The Siemens “Win an MRI" contest has closed and the polls are now open to award a MAGNETOM Essenza ...
December 7, 2007 - Edwards Lifesciences Corp. today has entered into a definitive agreement to sell certain assets related to the Edwards LifeStent peripheral vascular product line to C.R. Bard Inc. for up to $140 million. The transaction is expected to close in January 2008, pending regulatory approvals.
December 7, 2007 - Cardinal Health and HemCon Medical Technologies Inc. this week announced the availability of co ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V ...
December 6, 2007 - The first commercial implant of the Mitroflow Aortic Pericardial Heart Valve in the U.S. was ...
By Nadim Daher, Industry Analyst - Medical Imaging, Frost & Sullivan December 6, 2007 - More so than in previous years ...